Malaysian Genomics Resource Centre Bhd
KLSE:MGRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Malaysian Genomics Resource Centre Bhd
Common Stock
Malaysian Genomics Resource Centre Bhd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Malaysian Genomics Resource Centre Bhd
KLSE:MGRC
|
Common Stock
17.4m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
6%
|
|
Malaysian Genomics Resource Centre Bhd
Glance View
Malaysian Genomics Resource Centre Bhd. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2010-01-25. The company provides genome sequencing and analysis, and genetic screening services. The company offers end-to-end genomics services that comprise genome sequencing, genome analysis, and genetic screening. Its whole genome sequencing (WGS) is carried out to obtain the sequence of the entire genome from any eukaryotic or prokaryotic organism. This includes plant, animal, microbial, and human genomes. The company offers both de novo sequencing and resequencing as part of its WGS service. Its genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing. Its genetic screening includes Dtect, which offers a range of test panels designed to screen for genetic markers in an individual’s deoxyribonucleic acid (DNA). Dtect also screens for genetic markers related to adverse reactions towards drugs used in treating certain diseases. The company operates dialysis centers through MGRC Healthcare Sdn Bhd.
See Also
What is Malaysian Genomics Resource Centre Bhd's Common Stock?
Common Stock
17.4m
MYR
Based on the financial report for Dec 31, 2025, Malaysian Genomics Resource Centre Bhd's Common Stock amounts to 17.4m MYR.
What is Malaysian Genomics Resource Centre Bhd's Common Stock growth rate?
Common Stock CAGR 10Y
6%
Over the last year, the Common Stock growth was -71%. The average annual Common Stock growth rates for Malaysian Genomics Resource Centre Bhd have been -32% over the past three years , -9% over the past five years , and 6% over the past ten years .
